Targeting cancer testis antigens in synovial sarcoma by Geoffrey Mitchell, Seth M Pollack, Michael J Wagner

Get full text

Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report by Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, Hannah Knott, Rusul Al-Maryati, Farres Obeidin, Borislav A Alexiev, Susan Abbinanti, Senthil Damodaran, Mark Agulnik, Seth M Pollack

Get full text

Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy by Cassian Yee, Seth M Pollack, Robin L Jones, Jianhong Cao, Ernest U Conrad, Stanley R Riddell, Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, Shihong Zhang, Karan Kohli, Jose G Mantilla

Get full text

Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system by Xiaojing Tina Chen, Xiaojing Tina Chen, Matthias Leisegang, Matthias Leisegang, Ioannis Gavvovidis, Ioannis Gavvovidis, Seth M. Pollack, Felix K. M. Lorenz, Ton N. Schumacher, Ton N. Schumacher, Oliver Daumke, Thomas Blankenstein

Get full text

Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States by Seth M. Pollack, Neeta Somaiah, Dejka M. Araujo, Mihaela Druta, Brian A. Van Tine, Melissa A. Burgess, Sant P. Chawla, Mahesh Seetharam, Scott H. Okuno, Chet Bohac, Michael Chen, Sergey Yurasov, Steven Attia

Get full text